Fluo Labs

Fluo Labs

Seize the Sneeze

Print
Security Type
Common Stock
Categories
Health & Fitness
Min Investment
$250
Location
San Marcos, CA
Offering Date
June 23, 2021
Expected Close Date
December 20, 2021
Target Raise
$10.00K-$3.80M
Security Price
$1
Valuation
$12,000,000

Company Description

Fluo Labs is pioneering a potential breakthrough light-based technology designed to help allergy sufferers reduce their allergy symptoms without having to use medication. Over 50 Million Americans and 1 Billion more people worldwide suffer from allergies. And thanks to climate change, allergy seasons are only getting longer, more intense and affecting more and more people every year. And while the global allergy treatment market is growing and set to reach $40 billion by 2025, we believe it is under serviced, leaving 66% of allergy sufferers to report dissatisfaction with their current allergy medications.A team that’s changing allergy relief:  With multiple patents granted and filed and a successful proof-of-concept study, the team is now set to complete the clinical evaluations and final studies that are needed to obtain an FDA de Novo grant which we hope to obtain by the end of 2021.

Key Deal Facts

A new category in allergy care: Fluo Labs is pioneering a potential breakthrough light-based technology designed to help allergy sufferers reduce their allergy symptoms without having to use medication.
A huge and growing market: Over 50 Million Americans and 1 Billion more people worldwide suffer from allergies. And thanks to climate change, allergy seasons are only getting longer, more intense and affecting more and more people every year. And while the global allergy treatment market is growing and set to reach $40 billion by 2025, we believe it is under serviced, leaving 66% of allergy sufferers to report dissatisfaction with their current allergy medications.
A team that’s changing allergy relief: With multiple patents granted and filed and a successful proof-of-concept study, the team is now set to complete the clinical evaluations and final studies that are needed to obtain an FDA de Novo grant which we hope to obtain by the end of 2021.

Management Team / Advisory Board Bios

Richard Clement, M.D., F.A.C.S.,
Chairman of the Board of Directors and President of Fluo Labs, Inc.
President and Angel InvestorSerial investor and entrepreneur (CLRS Technology and Arrestage International). Dr. Clement is plastic surgeon and leads a successful practice in Scottsdale AZ.

Paul Rubin, MD, Chief Medical Officer
Extensive experience in multiple pharma/biotech therapeutic areas. Involved with discovery, preclinical and clinical development, regulatory and marketing in global and emerging drug companies. Experience with antihistamines and nasal steroids. GSK, Abbott, Xoma, Sepracor.

Jan Enemaerke, Chief Technology Officer
Expert in lasers and medical optical engineering. Senior executive positions (US & Europe). BSc in mechanical engineering, MBA.

Anne-Marie Kovacs, Chief Strategy Officer
Creative strategist to emerging companies. Marketing, strategic foresight, project management, operations, business development, brand management, creative development.

Lawrence Johnson, CEO
Seasoned entrepreneur, health informatics., data analytics, medical device start-ups. Board of CLRS Technology. Successful exits: yellowpages.com (digital), RightPond (fintech), CLRS (devices)
Amount Raised : $82,345
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments